106 related articles for article (PubMed ID: 11567210)
1. Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
Wissing S; Lippacher A; Müller R
J Cosmet Sci; 2001; 52(5):313-24. PubMed ID: 11567210
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
Pardeike J; Hommoss A; Müller RH
Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
Wissing SA; Müller RH
Pharmazie; 2001 Oct; 56(10):783-6. PubMed ID: 11683123
[TBL] [Abstract][Full Text] [Related]
4. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading.
Patravale VB; Ambarkhane AV
Pharmazie; 2003 Jun; 58(6):392-5. PubMed ID: 12857001
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
6. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
Saupe A; Gordon KC; Rades T
Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
[TBL] [Abstract][Full Text] [Related]
7. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
Müller RH; Petersen RD; Hommoss A; Pardeike J
Adv Drug Deliv Rev; 2007 Jul; 59(6):522-30. PubMed ID: 17602783
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
13. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
[TBL] [Abstract][Full Text] [Related]
14. Cosmetic applications for solid lipid nanoparticles (SLN).
Wissing SA; Müller RH
Int J Pharm; 2003 Mar; 254(1):65-8. PubMed ID: 12615411
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
Hu LD; Tang X; Cui FD
Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
Jaspart S; Piel G; Delattre L; Evrard B
Expert Opin Drug Deliv; 2005 Jan; 2(1):75-87. PubMed ID: 16296736
[TBL] [Abstract][Full Text] [Related]
17. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
18. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
20. Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla SH; Dingler A
Pharmazie; 2001 Jan; 56(1):61-3. PubMed ID: 11210672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]